Trial Profile
Use of CapAIBL for the Centiloid Transformation of 18F-NAV4694 and 18F-florbetaben
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Aug 2017
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary) ; Flutafuranol F 18 (Primary) ; Pittsburgh compound B
- Indications Alzheimer's disease
- Focus Diagnostic use
- 24 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017.
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017